Clinical Trial Update: Special Drug Use Surveillance of Entresto Tablets (Hypertension)

View source ↗

Summary

This clinical trial update covers Special Drug Use Surveillance for Entresto (sacubitril/valsartan) in hypertension and notes the study status as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Entresto (sacubitril/valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension | Status: COMPLETED